Smartleaf Asset Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.4K Hold
1,073
﹤0.01% 1904
2026
Q1
$23.8K Sell
1,073
-68
-6% -$1.56K ﹤0.01% 1849
2025
Q4
$27.3K Hold
1,141
﹤0.01% 1866
2025
Q3
$29.4K Buy
1,141
+67
+6% +$1.72K ﹤0.01% 1648
2025
Q2
$30.3K Sell
1,074
-115
-10% -$3.09K ﹤0.01% 1377
2025
Q1
$29.5K Sell
1,189
-35
-3% -$833 ﹤0.01% 1413
2024
Q4
$27.8K Buy
1,224
+806
+193% +$17.5K ﹤0.01% 1472
2024
Q3
$8.91K Buy
418
+181
+76% +$3.56K ﹤0.01% 1830
2024
Q2
$4.54K Buy
237
+91
+62% +$1.85K ﹤0.01% 1851
2024
Q1
$2.83K Sell
146
-2,175
-94% -$43.1K ﹤0.01% 1391
2023
Q4
$48.6K Buy
+2,321
New +$44.6K 0.01% 542

Other funds holding FMS

Smartleaf Asset Management's FMS Position: Q2 2026 in Review

Smartleaf Asset Management held its Fresenius Medical Care (FMS) position steady in Q2 2026 at 1,073 shares worth $24.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1904.

Smartleaf Asset Management first reported a position in FMS in Q4 2023 and has held it in 11 quarters since. The position peaked at $48.6K in Q4 2023. 234 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • Smartleaf Asset Management held 1,073 shares of Fresenius Medical Care worth $24.4K as of Q2 2026.
  • Smartleaf Asset Management left its Fresenius Medical Care share count unchanged in Q2 2026.
  • Fresenius Medical Care made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1904 holding.
  • Smartleaf Asset Management first reported a position in Fresenius Medical Care in Q4 2023 and has held it in 11 quarters since.
  • Smartleaf Asset Management's Fresenius Medical Care position peaked at $48.6K in Q4 2023.
  • 234 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.